INSM vs. CLS
INSM (Insmed Incorporated) and CLS (Celestica Inc.) are both stocks. INSM operates in Biotechnology (Healthcare), while CLS operates in Electronic Components (Technology). Over the past 10 years, INSM returned 24.71%/yr vs 42.61%/yr for CLS. At a 0.20 correlation, their price movements are largely independent.
Performance
INSM vs. CLS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INSM achieves a -43.09% return, which is significantly lower than CLS's 25.79% return. Over the past 10 years, INSM has underperformed CLS with an annualized return of 24.71%, while CLS has yielded a comparatively higher 42.61% annualized return.
INSM
- 1D
- 5.17%
- 1M
- -2.28%
- YTD
- -43.09%
- 6M
- -48.99%
- 1Y
- 40.12%
- 3Y*
- 71.02%
- 5Y*
- 27.78%
- 10Y*
- 24.71%
CLS
- 1D
- -3.79%
- 1M
- -0.98%
- YTD
- 25.79%
- 6M
- 8.72%
- 1Y
- 203.19%
- 3Y*
- 205.59%
- 5Y*
- 113.26%
- 10Y*
- 42.61%
INSM vs. CLS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
INSM Insmed Incorporated | -43.09% | 152.09% | 122.78% | 55.11% | -26.65% | -18.17% | 39.41% | 82.01% | -57.92% | 135.68% |
CLS Celestica Inc. | 25.79% | 220.27% | 215.23% | 159.80% | 1.26% | 37.92% | -2.42% | -5.70% | -16.32% | -11.56% |
Correlation
The correlation between INSM and CLS is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2000 | 0.21 |
The correlation between INSM and CLS shifts across timeframes, from 0.11 (1 year) to 0.23 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
INSM:
$21.34B
CLS:
$43.02B
INSM:
-$5.71
CLS:
$8.28
INSM:
25.07
CLS:
3.12
INSM:
30.28
CLS:
20.51
INSM:
$819.56M
CLS:
$13.81B
INSM:
$668.55M
CLS:
$1.60B
INSM:
-$1.14B
CLS:
$1.32B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INSM vs. CLS — Risk / Return Rank
INSM
CLS
INSM vs. CLS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Insmed Incorporated (INSM) and Celestica Inc. (CLS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| INSM | CLS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.14 | ||
| Sortino ratioReturn per unit of downside risk | -1.49 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.37 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 0.73 | 7.00 | -6.27 |
| Martin ratioReturn relative to average drawdown | 1.76 | 17.31 | -15.55 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| INSM | CLS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.68 | 2.82 | -2.14 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.38 | 1.98 | -1.59 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.32 | 0.86 | -0.54 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.02 | 0.27 | -0.29 |
Drawdowns
INSM vs. CLS - Drawdown Comparison
The maximum INSM drawdown since its inception was -98.65%, roughly equal to the maximum CLS drawdown of -96.93%. Use the drawdown chart below to compare losses from any high point for INSM and CLS.
Loading charts...
Drawdown Indicators
| INSM | CLS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.65% | -96.93% | -1.72% |
Max Drawdown (1Y)Largest decline over 1 year | -55.46% | -29.24% | -26.22% |
Max Drawdown (3Y)Largest decline over 3 years | -55.46% | -53.96% | -1.50% |
Max Drawdown (5Y)Largest decline over 5 years | -55.46% | -53.96% | -1.50% |
Max Drawdown (10Y)Largest decline over 10 years | -64.84% | -80.60% | +15.76% |
Current DrawdownCurrent decline from peak | -53.15% | -21.28% | -31.87% |
Average DrawdownAverage peak-to-trough decline | -86.09% | -73.34% | -12.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.91% | 11.79% | +11.12% |
Volatility
INSM vs. CLS - Volatility Comparison
The current volatility for Insmed Incorporated (INSM) is 19.09%, while Celestica Inc. (CLS) has a volatility of 26.77%. This indicates that INSM experiences smaller price fluctuations and is considered to be less risky than CLS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INSM | CLS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.09% | 26.77% | -7.68% |
Volatility (6M)Calculated over the trailing 6-month period | 45.36% | 55.22% | -9.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 59.33% | 72.51% | -13.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 72.79% | 57.65% | +15.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 78.48% | 49.94% | +28.54% |
Dividends
INSM vs. CLS - Dividend Comparison
Neither INSM nor CLS has paid dividends to shareholders.
Financials
INSM vs. CLS - Financials Comparison
This section allows you to compare key financial metrics between Insmed Incorporated and Celestica Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INSM vs. CLS - Profitability Comparison
INSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Insmed Incorporated reported a gross profit of 258.54M and revenue of 305.96M. Therefore, the gross margin over that period was 84.5%.
CLS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a gross profit of 437.20M and revenue of 4.05B. Therefore, the gross margin over that period was 10.8%.
INSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Insmed Incorporated reported an operating income of -198.20M and revenue of 305.96M, resulting in an operating margin of -64.8%.
CLS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported an operating income of 272.10M and revenue of 4.05B, resulting in an operating margin of 6.7%.
INSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Insmed Incorporated reported a net income of -163.56M and revenue of 305.96M, resulting in a net margin of -53.5%.
CLS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a net income of 212.30M and revenue of 4.05B, resulting in a net margin of 5.3%.
Frequently Asked Questions
INSM and CLS have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLS has higher volatility (26.77%) compared to INSM (19.09%). In terms of maximum drawdown, INSM dropped -98.65% vs CLS's -96.93%.
CLS currently has the higher Sharpe Ratio (2.82 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INSM and CLS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer